Artha Sootra - Company Dashboard

Governance Classic Home

Corona Remedies LtdPharmaceuticalsINE02ZQ01018Consolidated₹2399.55+125.25 (+5.51%)

Valuation

Market Cap₹14.71K Cr

TTM PE71.07x

Forward PE66.58x

PEG17.64

Book Value₹131.64

P/B18.28x

TTM EPS₹33.85

Fwd EPS₹36.13

TTM Revenue₹1.56K Cr

TTM PAT₹207.02 Cr

TTM EBITDA₹334.26 Cr

TTM EBIT₹286.22 Cr

Last Qtr PAT₹60.31 Cr

Last Qtr EBITDA₹95.95 Cr

Last Qtr EBIT₹80.89 Cr

Profitability

ROE25.71%

ROCE31.06%

TTM NPM13.28%

TTM EBITDA %21.44%

Curr OPM13.59%

Last OPM14.12%

Curr NPM—

Last NPM—

Curr EPS₹9.86

Last EPS₹9.83

Balance sheet

Equity₹61.16 Cr

Reserve₹743.95 Cr

Total Debt₹94.53 Cr

D/E0.12x

Interest %4.56%

Curr Interest₹2.75 Cr

Price / range

Close₹2405.80

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D+5.91%

1W+9.17%

1M+18.21%

3M+10.75%

6M+38.61%

1Y—

2Y—

3Y—

5Y—

Diwali—

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1773.40	₹4.25L Cr	38.81	12.31%
DIVISLAB	10037.50	₹2.66L Cr	91.08	17.45%
TORNTPHARM	4738.50	₹1.60L Cr	77.77	11.42%
LAURUSLABS	2323.80	₹1.25L Cr	93.63	21.98%
ZYDUSLIFE	1188.10	₹1.20L Cr	28.53	15.79%
DRREDDY	1374.00	₹1.15L Cr	40.89	7.11%
CIPLA	1402.00	₹1.13L Cr	39.09	8.06%
MANKIND	2537.90	₹1.05L Cr	46.71	12.87%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	441.17+22.2%	422.43	353.09	342.42	361.13	1,403.18
Other Income	2.48	3.15	4.11	2.24	2.27	10.65
Total Income	443.65+22.1%	425.58	357.20	344.66	363.40	1,413.83
Interest	2.75	2.69	1.38	1.66	1.93	6.97
Expenditure	-363.03-23.6%	-345.23	-302.74	-270.37	-293.79	-1,154.58
PBDT	0	0	0	0	0	0
EBITDA	95.95+22.3%	93.13	62.02	83.16	78.47	293.44
Depreciation	-15.06	-13.24	-10.29	-9.45	-9.20	-37.87
EBIT	80.89+16.8%	79.89	51.73	73.71	69.27	255.57
PBT	80.62+15.8%	80.35	54.46	55.19	69.61	240.15
Tax	-20.44	-20.25	-9.41	-13.94	-17.46	-55.30
Equity	61.16	61.16	61.16	0	61.16	61.16
OPM	18.17	18.88	15.25	16.12	19.16	16.99
Net Profit	60.18+15.4%	60.10	45.05	41.25	52.15	184.85
NPM	13.56	14.12	12.61	12.05	14.35	13.07
EPS	9.84+15.4%	9.83	7.37	6.74	8.53	30.22

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26
Revenue	1,403.18
Other Income	10.65
Total Income	1,413.83
Expenditure	-1,154.58
Interest	-6.97
PBDT	0
EBITDA	293.44
Depreciation	-37.87
EBIT	255.57
PBT	240.15
Tax	-55.30
Equity	61.16
OPM (%)	16.99
Net Profit	184.85
NPM (%)	13.07
EPS (Rs)	30.22
CEPS	30.22

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	441.17+22.2%	422.43	353.09	342.42	361.13	1,403.18
Other Income	2.48	3.15	4.11	2.24	2.27	10.65
Total Income	443.65+22.1%	425.58	357.20	344.66	363.40	1,413.83
Interest	2.75	2.69	1.38	1.66	1.93	6.97
Expenditure	-363.03-23.6%	-345.23	-302.74	-270.37	-293.79	-1,154.58
PBDT	0	0	0	0	0	0
EBITDA	95.95+22.3%	93.13	62.02	83.16	78.47	293.44
Depreciation	-15.06	-13.24	-10.29	-9.45	-9.20	-37.87
EBIT	80.89+16.8%	79.89	51.73	73.71	69.27	255.57
PBT	80.62+15.8%	80.35	54.74	55.21	69.61	240.42
Tax	-20.44	-20.25	-9.41	-13.94	-17.46	-55.30
Equity	61.16	61.16	61.16	0	61.16	61.16
OPM	18.17	18.88	15.32	16.02	19.16	17.00
Net Profit	60.31+15.3%	60.11	45.33	41.27	52.32	185.12
NPM	13.59	14.12	12.69	11.97	14.40	13.09
EPS	9.86+15.3%	9.83	7.41	6.75	8.55	30.27

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26
Revenue	1,403.18
Other Income	10.65
Total Income	1,413.83
Expenditure	-1,154.58
Interest	-6.97
PBDT	0
EBITDA	293.44
Depreciation	-37.87
EBIT	255.57
PBT	240.42
Tax	-55.30
Equity	61.16
OPM (%)	17.00
Net Profit	185.12
NPM (%)	13.09
EPS (Rs)	30.27
CEPS	30.27

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2026	Final Dividend	10	19 Jun 2026

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split